Why Catalent Stock Zoomed 12% Higher This Week
(NYSE: CTLT) is one company that probably wishes the summer would never end. As August came to a close, the contract drug manufacturer's stock enjoyed a nearly 12% rise over the course of the month's final week. That's according to data compiled by S&P Global Market Intelligence.
Catalent's happy week kicked off on Tuesday, when the company unveiled its preliminary fourth-quarter and full-year 2023 results. These showed that both revenue and non-GAAP (adjusted) net profit saw year-over-year declines.
Yet expectations for Catalent, which has struggled with a series of production difficulties at three of its factories, were quite low.
Source Fool.com
Catalent Inc. Aktie
54,83 €
-0,51 %
Die Catalent Inc. Aktie hat nicht genug Einschätzungen für ein klares Sentiment.
Das von der Community festgelegte Kursziel von 55 € für Catalent Inc. wurde mit dem aktuellen Kurs von 54.83 € erreicht.
